DABRAFENIB vs OSIMERTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DABRAFENIB vs OSIMERTINIB: Safety Overview
| Metric | DABRAFENIB | OSIMERTINIB |
|---|---|---|
| Total FAERS Reports | 19,305 | 27,750 |
| Deaths Reported | 4,165 | 12,456 |
| Death Rate | 21.6% | 44.9% |
| Hospitalizations | 5,325 | 5,277 |
| Average Patient Age | 58.3 yrs | 68.2 yrs |
| % Female Patients | 48.0% | 66.0% |
| FDA Approval Date | Mar 16, 2023 | Nov 13, 2015 |
| Manufacturer | Novartis Pharmaceuticals Corporation | AstraZeneca Pharmaceuticals LP |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |